Lotus Set To Build New Manufacturing Facility, Pharma Park In Inner Mongolia
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Lotus Pharmaceuticals, a Beijing-based drug maker and a distributor of Western medicines, is channeling RMB 180 million ($26.3 million) into establishing a new manufacturing base and pharmaceutical park in Inner Mongolia, according to company executives
You may also be interested in...
Lotus Pharmaceutical Registers Increased Q1 Growth; Will Pursue Acquisitions, Product Diversification
SHANGHAI - Beijing-based Lotus Pharmaceuticals will further diversify its product portfolio and make acquisitions in the long term, the company said at the back of announcing increased growth figures over the first quarter ended March 31
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).